RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer.

Authors:
Chen X; Dong X; Li H; Wu T; Liu H and 4 more

Journal:
Cancer Cell Int

Publication Year: 2024

DOI:
10.1186/s12935-024-03257-w

PMCID:
PMC10882920

PMID:
38383371

Journal Information

Full Title: Cancer Cell Int

Abbreviation: Cancer Cell Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Evidence found in paper:

"the raw data and script of r code was uploaded as additional materials."

Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Southwest hospital [KY2022151]. Informed consentInformed consent was obtained from all subjects involved in the study. Competing interestsThe authors declare no conflict of interest. Competing interests The authors declare no conflict of interest."

Evidence found in paper:

"Funding This research was funded by National Natural Science Foundation, grant number 81803279."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025